Target intelligence / Profile preview

Dermatophagoides siboney allergen (Der s)

Target
Der s
Molecular classification
Cysteine protease, NPC2-like protein, Lipid-binding protein, Serine protease, Tropomyosin
01

Overview

Dermatophagoides siboney allergens are a complex group of proteins produced by the tropical house dust mite species D. siboney, which is a major source of indoor allergens in the Caribbean and surrounding regions (Ferrándiz et al., 1996, PMID: 8646100). The most clinically significant components are Der s 1, a cysteine protease, and Der s 2, a member of the NPC2-like lipid-binding protein family (WHO/IUIS Allergen Nomenclature, allergen.org). These allergens act as potent antigens that trigger Type I hypersensitivity reactions by cross-linking IgE on the surface of mast cells and basophils, leading to the release of inflammatory mediators (PubMed: 15985814). In the context of therapeutic intervention, these allergens are the primary components of allergen-specific immunotherapy (AIT) formulations, such as Valergen-DS (Labarta et al., 2006, PMID: 16846561). The goal of such therapy is to desensitize the patient's immune system, promoting the development of regulatory T cells and the production of protective IgG4 antibodies. Understanding the molecular structure and biological activity of these allergens is essential for improving diagnostic accuracy and the efficacy of immunotherapy for allergic asthma and rhinitis (UniProt: P49274, P49275).

Other names
House dust mite allergenD. siboney allergenDer s 1Der s 2Der s 3Der s 5Der s 7Der s 10Der s 11Der s 14Der s 20Der s 21
02

Mechanism of action

Induction of immune tolerance through the modulation of T-cell responses, shifting from a Th2-dominated profile to a Th1/Treg-dominated profile, and increasing the production of blocking antibodies such as IgG4.

03

Biological functions

ProteolysisLipid transportImmune response inductionAllergenicity
04

Disease associations

Allergic asthmaAllergic rhinitisAtopic dermatitisInflammation
05

Safety considerations

AnaphylaxisSystemic allergic reactionsLocal injection site reactionsExacerbation of asthma symptoms
06

Interacting drugs

Valergen-DS

1 more in the full profile.

07

Biomarkers

Specific IgE (sIgE)Specific IgG4 (sIgG4)Skin prick test (SPT) reactivity

Beyond the preview

Go deeper on Dermatophagoides siboney allergen (Der s).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dermatophagoides siboney allergen (Der s).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call